Cardiology Headline News

Decreased intake of extra-virgin olive oil within a whole-food, plant-based diet may help to lower LDL among individuals at risk for atherosclerotic CVD, according to a study published in Journal of the American Heart Association.

Health care providers know of the broad potential AI offers for reducing burnout, but which products are actually available for use can be difficult to ascertain, especially considering electronic health record system compatibility.

The number of monthly prescription fills for semaglutide increased by 442% from 2021 to 2023, according to a research letter published in JAMA Health Forum.

High-quality CT and stress testing should be able to effectively and safely diagnose patients with stable chest pain and suspected CAD, regardless of BMI, while improving clinical efficiency, researchers reported.

Many people who experience side effects from cancer treatment wait nearly a month to see a specialist with the necessary expertise.

Tirzepatide significantly reduced HF outcomes and symptoms for patients with HF and preserved ejection fraction and obesity, according to the top-line results of the phase 3 SUMMIT clinical trial.

With the use of AI-enabled quantitative coronary plaque analysis, researchers developed nomograms designed to improve risk stratification of patients who may be at risk for atherosclerosis.

Explanations of echocardiography findings written using ChatGPT may be suitable to educate patients about their health status and reduce physician workload, according to data published in JACC: Cardiovascular Imaging.

Risk for psychiatric disorder or suicide attempt is particularly high in the first year following hospitalization for heart disease, and patient support is important to lower such risk, researchers reported.

Obicetrapib significantly reduced LDL vs. placebo in adults with heterozygous familial hypercholesterolemia and uncontrolled LDL, despite maximally tolerated therapy, according to the top-line results of the phase 3 BROOKLYN clinical trial.